Pharmaceutical Gelatin Global Market Report 2024

The pharmaceutical gelatin market size has grown strongly in recent years. It will grow from $1.21 billion in 2023 to $1.3 billion in 2024 at a compound annual growth rate (CAGR) of 6.8%. The growth observed in the historic period can be attributed to several key factors, including the expansion of the pharmaceutical industry, a growing preference for capsule dosage forms, increasing health awareness among consumers, and rising demand for gelatin capsules compliant with halal and kosher dietary requirements. These factors collectively contributed to the proliferation of capsule products in the market, driven by consumer preferences for convenient and easily consumable dosage forms, coupled with a heightened focus on health and dietary considerations, including religious dietary restrictions.

The pharmaceutical gelatin market size is expected to see strong growth in the next few years. It will grow to $1.67 billion in 2028 at a compound annual growth rate (CAGR) of 6.5%. The forecasted growth can be attributed to a surge in nutraceutical demand, a rising geriatric population, sustainable practices, eco-friendly solutions, and growth in the global pharmaceutical industry. Major trends in the forecast period include a shift towards plant-based alternatives, advancements in drug delivery systems, technological improvements in gelatin production, and the evolution of capsule dosage forms.

The pharmaceutical gelatin market is expected to experience growth due to the rising demand for health and wellness. Health and wellness encompass a holistic approach to well-being, including physical, mental, and social aspects of health. Pharmaceutical gelatin plays a crucial role in health and wellness by facilitating the safe and effective delivery of medications, enhancing their efficacy, and reducing the need for frequent dosing. For example, Wellness Creative Co, a UK-based wellness company, predicts that the health and wellness sector will reach $7.2 trillion by 2025, growing at an annual rate of 8.5%. This increasing demand for health and wellness is a key driver behind the growth of the pharmaceutical gelatin market.

In the pharmaceutical gelatin market, major companies are introducing advanced solutions such as Easyseal gelatin to reduce production costs associated with soft gel leakers. Easyseal addresses this issue by incorporating optimized seam forming and enhanced seam thickness and stability, making soft capsules more resilient to physical stress and mitigating leaker problems. For example, in December 2023, GELITA MEDICAL GmbH launched Easyseal gelatin, offering reduced dependency on sealing temperature compared to other gelatins and superior drying properties. This innovation enhances energy efficiency and overall production capacity, enabling reliable sealing at high speeds, especially for challenging-to-fill suspensions. It is particularly beneficial for products requiring special equipment, such as double-step die tooling.

In April 2023, Darling Ingredients Inc., a US-based manufacturer of animal food, acquired Gelnex Gelatin for an undisclosed amount. This acquisition provides Darling Ingredients with increased production capacity to meet the growing demands of its collagen customers and enables the company to better serve the expanding market for gelatin and collagen. Gelnex Gelatin, based in Brazil, specializes in manufacturing gelatin and collagen products for pharmaceutical applications.

Major companies operating in the pharmaceutical gelatin market report are Nitta Gelatin Inc., Lonza Group AG, Darling Ingredients Inc., Catalent Inc., Tessenderlo Group NV, Gelita AG, Rousselot Inc., Weishardt & Co. KG, Batotau Dongbao Bio-Tech, Nippi Collagen Co. Ltd., Apex Pharma Ltd., Narmada Gelatines Ltd., Aspire Pharmaceuticals Pvt. Ltd., Sterling Gelatin Limited, Junca Gelatines SL, Trobas Pharmaceutical gelatine B.V., Gelco International, Reichert Gruppe Ingredients GmbH, Norland Products Inc., Lapi Gelatine S.p.a., Italgelatine S.p.A, Kenney & Ross Limited, Norland Products Inc., Xiamen Yasin industry & Trade Co. Ltd., PB Gelatins SA.

North America was the largest region in the pharmaceutical gelatin market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical gelatin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pharmaceutical gelatin market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Pharmaceutical gelatin, tailored specifically for use in medications and medical applications, is derived from collagen, a protein sourced from animal connective tissues. This gelatin undergoes rigorous purification processes to adhere to stringent safety and quality standards and is utilized primarily for its ability to form a protective barrier against light, moisture, and oxygen.

The primary types of pharmaceutical gelatin include type A and type B. Type A gelatin is manufactured using the acid method, which entails collagen hydrolysis in the presence of an acid. It serves various functions such as stabilizing, thickening, and gelling, and is sourced from animals such as porcine, bovine skin, bovine bone, marine sources, and poultry. These gelatins find application in a range of pharmaceutical products, including hard capsules, soft gel capsules, tablets, absorbable hemostats, and others.

The pharmaceutical gelatin market research report is one of a series of new reports that provides pharmaceutical gelatin market statistics, including pharmaceutical gelatin industry global market size, regional shares, competitors with pharmaceutical gelatin market share, detailed pharmaceutical gelatin market segments, market trends, and opportunities, and any further data you may need to thrive in the pharmaceutical gelatin industry. This pharmaceutical gelatin market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The pharmaceutical gelatin market consists of sales of pharmaceutical gelatin sourced from cattle bones, natural and marine sources gelatin. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.